Green light for 10 new medicines in November 2025
The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of […]
The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of […]
The EU drug watchdog, the European Medicines Agency (EMA), has launched a partnership with social media influencers to promote the safe use of GLP-1 receptor agonists. The #HealthNotHype […]
Young people in Scotland are experimenting with nicotine pouches and reporting adverse effects such as sickness and fainting, according to new research from the Scottish Centre for Social […]
In June 2022, the U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization ended the federal constitutional right to abortion and returned authority to individual states […]
The spread of illegally manufactured fentanyl has driven overdose deaths to unprecedented levels in the United States and Canada. It has also changed the production function for drug […]
New research from The University of Texas at Arlington shows that differences in state welfare policies are linked to rising arthritis-related joint pain across much of the U.S. […]
Calorie labelling, which became law in April 2022 in England, is associated with only a small (2%) average reduction in the energy content of food that is available […]
The European Medicines Agency (EMA) has recommended 14 new medicines for approval at its September meeting. The key Committee on Human Medicinal Products (CHMP) reviews safety and efficacy […]
The European Medicines Agency (EMA) is working on guidelines for the inclusion of pregnant and breastfeeding individuals in clinical trials. The recommendations are designed to support better information […]
Soaring demand for GLP-1 receptor agonists, commonly prescribed for diabetes and obesity, is driving a surge in the online sale of illegal medicines. The European Medicines Agency (EMA) […]
Medicines containing a type of PFAS or ‘forever chemical’ called fluorine are not leading to higher numbers of adverse drug reactions according to new data analysis. In a […]
Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds […]
ADVERTISMENT
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
